Evidence map›Paper›PMID 34142651›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2021

Impact of the COVID-19 pandemic on tuberculosis national reference laboratory services in the WHO European Region, March to November 2020.

Florian P Maurer, Natalia Shubladze, Gulmira Kalmambetova, Irina Felker, Giorgi Kuchukhidze, Francis Drobniewski, Askar Yedilbayev, Soudeh Ehsani, European Laboratory Initiative on TB, HIV and Viral Hepatitis, Additional members of the European Laboratory Initiative on TB, HIV and Viral Hepatitis core group (in alphabetical order)

Erratum issuedOpen access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Performance of direct detection ofMicrobiology spectrum · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The COVID-19 and TB syndemic: the way forward.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2022
    Review
  9. Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2022
    Article
  10. Article
  11. Time to regain lost ground: Tuberculosis in the COVID-19 era.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2021
    Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 5 countries.

Florian P MaurerNational and WHO Supranational Reference Laboratory for Mycobacteria, Research Center Borstel, Leibniz Lung Center, Borstel, Germany.
Natalia ShubladzeNational Reference Laboratory, National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
Gulmira KalmambetovaNational TB Reference Laboratory, Bishkek, Kyrgyzstan.
Irina FelkerScientific department, Novosibirsk Tuberculosis Research Institute, Novosibirsk, Russia.
Giorgi KuchukhidzeRegional Office for Europe, World Health Organization, Copenhagen, Denmark.
Francis DrobniewskiInfectious Diseases, Faculty of Medicine, Imperial College London, London, United Kingdom.
Askar YedilbayevRegional Office for Europe, World Health Organization, Copenhagen, Denmark.
Soudeh EhsaniRegional Office for Europe, World Health Organization, Copenhagen, Denmark.
European Laboratory Initiative on TB, HIV and Viral HepatitisThe named authors are members of the European Laboratory Initiative on TB, HIV and Viral Hepatitis core group. The additional members of the European Laboratory Initiative on TB, HIV and Viral Hepatitis core group are listed under Investigators.
Additional members of the European Laboratory Initiative on TB, HIV and Viral Hepatitis core group (in alphabetical order)
World Health Organization Regional Office for Europe · DKImperial College London · GBNational Center for Tuberculosis and Lung Disease · GENovosibirsk Tuberculosis Research Institute · RUUniversität Hamburg · DE

Funding

Emory-Georgia TB Research Training ProgramD43TW007124 · FIC · EMORY UNIVERSITY · PI HENRY M BLUMBERG, Nestani Tukvadze · 2004 to 2026
$4.6M
FIC NIH HHS D43 TW007124World Health Organization 001
6 · The paper itself

Abstract

We assessed the impact of COVID-19 on diagnostic services for tuberculosis (TB) by national reference laboratories in the WHO European Region. Of 35 laboratories, 30 reported declines in TB sample numbers, amounting up to > 50% of the pre-COVID-19 volumes. Sixteen reported reagent or consumable shortages. Nineteen reallocated ressources to SARS-CoV-2 testing, resulting in an overall increase in workload, largely without a concomitant increase in personnel (n = 14). This poses a risk to meeting the 2025 milestones of the End TB Strategy.

Indexed as

COVID-19TuberculosisCOVID-19 TestingHumansLaboratoriesPandemicsSARS-CoV-2World Health OrganizationdiagnosticsPCRSARS-CoV-2

Identifiers

PMID34142651
PMCPMC8212594
OpenAlexW3168336371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.